Pfizer to buy Biohaven for $11.6 billion

Pfizer Inc. announced on Tuesday that it is acquiring Biohaven Pharmaceutical Holding Co. Ltd. in a deal worth $11.6 billion or $148.50 per share in cash. Biohaven common shareholders will also receiv…